comparemela.com

Latest Breaking News On - Hedge funds weigh in on tonix pharmaceuticals - Page 2 : comparemela.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews com

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report report published on Friday. The firm issued a sell rating on the stock. Tonix Pharmaceuticals Stock Performance Tonix Pharmaceuticals stock opened at $0.40 on Friday. The company’s 50 day simple moving average is $0.48 and its 200-day simple moving […]

Short Interest in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Increases By 308 7%

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,500,000 shares, a growth of 308.7% from the November 30th total of 367,000 shares. Approximately 5.6% of the company’s stock are sold […]

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews com

StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the stock. Tonix Pharmaceuticals Price Performance NASDAQ:TNXP opened at $0.57 on Wednesday. The firm has a 50 day simple moving average of $0.51 and a 200-day simple moving average […]

StockNews com Begins Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP)

StockNews.com started coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the stock. Separately, Alliance Global Partners lowered their price target on Tonix Pharmaceuticals from $18.00 to $8.00 and set a buy rating for the company in […]

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews com

StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Get Rating) in a research report report published on Sunday morning. The firm issued a sell rating on the stock. Separately, Alliance Global Partners reiterated a buy rating and issued a $6.50 price target on shares of Tonix Pharmaceuticals in a research note on Thursday, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.